ExLibris header image
SFX Logo
Title: Breakthrough of the year 2013. Notable developments
Source:

Science [0036-8075] yr:2013


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Swann, J. "Immune surveillance of tumors." The journal of clinical investigation 117.5: 1137-1146. Link to SFX for this item
2. Gunturi, A. "Potential of New Therapies like Anti-PD1 in Kidney Cancer." Current treatment options in oncology 15.1 (2014): 137-146. Link to SFX for this item
3. "Breakthrough of the year 2013. ...Areas to watch in 2014." Science 342.6165 (2013): 1443-1443. Link to SFX for this item
4. Bhardwaj, N. "Harnessing the immune system to treat cancer." The journal of clinical investigation 117.5 (2007): 1130-6. Link to Full Text for this item Link to SFX for this item
5. Curiel, Tyler J J. "Tregs and rethinking cancer immunotherapy." The journal of clinical investigation 117.5 (2007): 1167-74. Link to Full Text for this item Link to SFX for this item
6. Drake, Evan G. "Tumor Regression and Allograft Rejection after Administration of Anti-PD-1." The New England Journal of Medicine 374.9 (2016): 896-898. Link to SFX for this item
7. Hafez, N. "Could PD-L1 prove to be an effective therapeutic target for bladder cancer?" Immunotherapy 7.1 (2015): 1-2. Link to SFX for this item
8. Mackiewicz, J. "Immunotherapy in advanced cutaneous melanoma patients." Przeglad Menopauzalny 17.5 (2013): 429-433. Link to SFX for this item
9. Smith, Nathaniel E. "t(6;11) Renal Cell Carcinoma (RCC): Expanded Immunohistochemical Profile Emphasizing Novel RCC Markers and Report of 10 New Genetically Confirmed Cases." The American journal of surgical pathology 38.5 (2014): 604-14. Link to SFX for this item
10. Fischer, Johannes C. "Diagnostic leukapheresis enables reliable detection of circulating tumor cells of nonmetastatic cancer patients." Proceedings of the National Academy of Sciences of the United States of America 110.41 (2013): 16580-16585. Link to Full Text for this item Link to SFX for this item
11. Topalian, Suzanne L. "Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer." The New England journal of medicine 366.26 (2012): 2443-2454. Link to SFX for this item
12. Han, J. "MyD88 beyond Toll." Nature immunology 7.4 (2006): 370-1. Link to Full Text for this item Link to SFX for this item
13. Nelson, B. "The impact of T-cell immunity on ovarian cancer outcomes." Immunological reviews 222.1 (2008): 101-116. Link to Full Text for this item Link to SFX for this item
14. Li, L. "Loss of the innate immunity negative regulator IRAK-M leads to enhanced host immune defense against tumor growth." Molecular immunology 44.14 (2007): 3453-61. Link to SFX for this item
15. Knutson, Lupe G L. "CD4 regulatory T cells in human cancer pathogenesis." Cancer immunology, immunotherapy 56.3 (2007): 271-285. Link to Full Text for this item Link to SFX for this item
16. Brahmer, Julie R. "Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer." The New England journal of medicine 366.26 (2012): 2455-2465. Link to SFX for this item
17. Allavena, P. "The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance." Immunological reviews 222.1 (2008): 155-161. Link to Full Text for this item Link to SFX for this item
18. Hodi, Steven S. "Improved Survival with Ipilimumab in Patients with Metastatic Melanoma." New England Journal of Medicine, The 363.8 (2010): 711-723. Link to SFX for this item
19. Topalian, Suzanne L. "Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity." Current opinion in immunology 24.2 (2012): 207-212. Link to SFX for this item
20. Wang, Helen Y Y. "Regulatory T cells and cancer." Current opinion in immunology 19.2 (2007): 217-23. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.